Chlamydia infection screening: Difference between revisions
Aditya Ganti (talk | contribs) |
m (Changes made per Mahshid's request) |
||
| Line 29: | Line 29: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Primary care]] | [[Category:Primary care]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
Revision as of 17:23, 18 September 2017
|
Chlamydia infection Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Chlamydia infection screening On the Web |
|
American Roentgen Ray Society Images of Chlamydia infection screening |
|
Risk calculators and risk factors for Chlamydia infection screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2], Aysha Anwar, M.B.B.S[3]
Overview
According to the CDC's 2015 Sexually Transmitted Diseases Treatment Guidelines, screening for chlamydia is recommended for sexually active women under 25 years, women over 25 who are at increased risk, all pregnant women under 25 years, pregnant women over 25 who are at increased risk, men who have sex with men, and individuals with HIV.[1][2]
Screening
According to the CDC's 2015 Sexually Transmitted Diseases Treatment Guidelines, screening for chlamydia is recommended. The guidelines are as follows:[1][2]
Women
- Sexually active women under 25 years of age
- Sexually active women aged 25 years and older if at increased risk
- Retest approximately 3 months after treatment if necessary
Pregnant Women
- All pregnant women under 25 years of age
- Pregnant women aged 25 and older if at increased risk
- Retest during the 3rd trimester for women under 25 years of age or at risk
Men
- Consider screening young men in high-prevalence clinical settings or in populations with high burden of infection (e.g., MSM)
- At least annually for sexually active men who have sex with men (MSM) and then every 3 to 6 months if at increased risk
Individuals with HIV
- For sexually active individuals, screen at first HIV evaluation and at least annually thereafter
- More frequent screening might be appropriate depending on individual risk behaviors and local epidemiology
References
- ↑ 1.0 1.1 Screening Recommendations Referenced in Treatment Guidelines and Original Recommendation Sources. CDC. http://www.cdc.gov/std/tg2015/screening-recommendations.htm. Accessed on January 6th, 2016
- ↑ 2.0 2.1 Screening recommendation for chlamydia. UPSTF. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/chlamydia-and-gonorrhea-screening?ds=1&s=chlamydia(2014). Acessed on September 8, 2016